Literature DB >> 7588838

Fluconazole in the treatment of three cases of mucormycosis.

R Koçak, T Tetiker, M Koçak, F Başlamişli, S Zorludemir, G Gönlüşen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7588838     DOI： 10.1007/BF02113443

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  5 in total

1.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

2.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.

Authors:  S L Chuck; M A Sande
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

Review 3.  Oral azole drugs as systemic antifungal therapy.

Authors:  J A Como; W E Dismukes
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  Twenty-five years' experience treating cerebro-rhino-orbital mucormycosis.

Authors:  E Abedi; A Sismanis; K Choi; P Pastore
Journal:  Laryngoscope       Date:  1984-08       Impact factor: 3.325

5.  Fluconazole in the treatment of persistent coccidioidomycosis.

Authors:  A Catanzaro; J Fierer; P J Friedman
Journal:  Chest       Date:  1990-03       Impact factor: 9.410
  5 in total
  8 in total

1.  Zygomycotic gangrenous cellulitis in a patient with non-insulin dependent diabetes mellitus.

Authors:  O Zimhony; E Israeli; S D Malnick; A Pansky; P Cohen; D Geltner
Journal:  West J Med       Date:  1998-03

2.  Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles.

Authors:  A M Sugar; X P Liu
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

3.  Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report.

Authors:  A A Cagatay; S S Oncü; S S Calangu; T T Yildirmak; H H Ozsüt; H H Eraksoy
Journal:  BMC Infect Dis       Date:  2001-11-23       Impact factor: 3.090

Review 4.  Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment.

Authors:  R Herbrecht; S Neuville; V Letscher-Bru; S Natarajan-Amé; O Lortholary
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

5.  Role of granulocyte colony-stimulating factor in the treatment of mucormycosis.

Authors:  B Sahin; S Paydaş; E Coşar; K Biçakçi; B Hazar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

6.  Rhino-oculo Cerebral Mucormycosis with Multiple Cranial Nerve Palsy in Diabetic Patient: Review of Six Cases.

Authors:  Kavita Sachdeva
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-05-14

7.  A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.

Authors:  Nan Jiang; Guiqiu Zhao; Shanshan Yang; Jing Lin; Liting Hu; Chengye Che; Qian Wang; Qiang Xu
Journal:  BMC Ophthalmol       Date:  2016-01-12       Impact factor: 2.209

8.  Concurrent pulmonary zygomycosis and Mycobacterium tuberculosis infection: a case report.

Authors:  Tejal Patel; Ian J Clifton; Jack A Kastelik; Daniel G Peckham
Journal:  J Med Case Rep       Date:  2007-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.